You are here : Home / All Sectors / Healthcare / Pharmaceuticals & Drugs / SANOFI INDIA

SANOFI INDIA
Intrinsic Value | Fundamental Analysis

Returns | 1W : -3.6% , 1M : -11.7%,1Y : -2.6%
www.aventispharmaindia.com
BOM : 500674     NSE : SANOFI    
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Sep 17,2021
Price(EOD): Rs. 7,913.90
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Affiliate Link.
Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

Check out Industry Peers

Peers & Returns1W1M1Y
SANOFI INDIA -3.6% -11.7% -2.6%
SUN PHARMACEUTICAL INDUSTRIES -1.3% -1.8% 54.5%
DR REDDYS LABORATORIES -0.9% 4% 12.1%
DIVIS LABORATORIES 0.8% 4.4% 63.9%
CIPLA 0.4% 5.5% 31.5%
BIOCON 6.8% 2.9% -12.9%
AUROBINDO PHARMA 1.3% 2% -6%
LUPIN -3.4% -2.4% 0.1%
TORRENT PHARMACEUTICALS -0.9% 3% 9.7%


FUNDAMENTAL ANALYSIS OF SANOFI INDIA

 
Fundamentals Score
[ Q(TTM): Jun2021, Y: Dec2020
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]
Show Me the Stocks with Fundamentals better than SANOFI INDIA Plus/Pro


VALUATION OF SANOFI INDIA

 
Valuation Score
[As on : Sep 17,2021 ]

Ratio Standalone
P/E
P/B
P/S
38.11
P/E Calculated based on EPS of 207.65
[ Dec2020 - Standalone Results ]

8.81
P/B Calculated based on Book Value of 897.83
[ Dec2020 - Standalone Results ]

6.23
P/S Calculated based on Revenues of 2921.1 Cr
[ TTM - Standalone Results ]

Show Me the Stocks with Valuation better than SANOFI INDIA Plus/Pro


FAIR VALUE OF SANOFI INDIA

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
98%
59%
63%

SHARE PRICE MOMENTUM OF SANOFI INDIA

DEBT

Year Debt/Equity ratio
Standalone Consolidated
2020
2019
2018
Avg_3yrs
0
0
0
-
-
-
-
-
[Last Annual Data : Dec2020]

PLEDGED SHARES

Pledged Shares
0 %
As on : Jun2021

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad

QTRLY RESULTS

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
8.83%
30.46%
24.47%
22.21%
11.06%
39.45%
30.08%
30.81%
QtrlyTrend
8
Latest Qtr: Jun2021

SANOFI INDIA related INDICES

BSE Indices1W1M1Y
S&P BSE 200 1.2% 6.4% 57.7%
S&P BSE 250 LARGEMIDCAP 1.2% 6.4% 58.2%
S&P BSE 150 MIDCAP 1.2% 6.4% 78.8%
S&P BSE ALLCAP 1.2% 6.3% 61.2%
S&P BSE 500 1.2% 6.4% 60%
S&P BSE 400 MIDSMALLCAP 1% 6.2% 82.3%
S&P BSE MIDSMALLCAP 0.8% 7.5% 84%
S&P BSE SMALL CAP 0.5% 6.6% 94.4%
S&P BSE SMALLCAP SELECT INDEX 0.2% 8% 89.7%
S&P BSE HEALTHCARE -0.2% 1.3% 42.6%
NSE Indices1W1M1Y
NIFTY FREE MIDCAP 100 1.5% 8.3% 80.6%
NIFTY MIDCAP150 1.3% 7.6% 77.5%
NIFTY LARGE MIDCAP 250 1.3% 7% 65.9%
NIFTY 200 1.3% 6.6% 57.6%
NIFTY 500 1.2% 6.5% 59.9%
NIFTY DIV OPPS 50 1.2% 5.2% 55.5%
NIFTY500 MULTICAP 50:25:25 1% 6.6% NA
NIFTY MID SMALL400 1% 7.1% 81.9%
NIFTY MIDCAP150 QUALITY 50 0.7% 6.1% NA
NIFTY MNC -0.2% 6.1% 37.9%
NIFTY HEALTHCARE -0.3% 1.2% NA

FAQ [Frequently Asked Questions]


Is SANOFI INDIA good for long term investment?

As on 17-Sep-2021, the Fundamentals of SANOFI INDIA look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of SANOFI INDIA . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is SANOFI INDIA UnderValued or OverValued?

As on 17-Sep-2021, SANOFI INDIA is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of SANOFI INDIA ?

As on 17-Sep-2021, the Intrinsic Value of SANOFI INDIA is Rs. 4,869.83 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 3,995.00
Fair Value [Median EV / Sales Model] : Rs. 4,982.74
Fair Value [Median Price / Sales Model] : Rs. 4,869.83
Median Fair Value of SANOFI INDIA : Rs. 4,869.83

Is SANOFI INDIA trading at a Premium or Discount?

As on 17-Sep-2021, SANOFI INDIA is trading at a Premium of 63% based on the estimates of Median Intrinsic Value!

What is the Financial Performance of Industry Peers of SANOFI INDIA ?

Check out Annual Financials of Industry Peers
Share Price & Financials of SUN PHARMACEUTICAL INDUSTRIES LTD | BOM: 524715 | NSE: SUNPHARMA
Share Price & Financials of DR REDDYS LABORATORIES LTD | BOM: 500124 | NSE: DRREDDY
Share Price & Financials of DIVIS LABORATORIES LTD | BOM: 532488 | NSE: DIVISLAB
Share Price & Financials of CIPLA LTD | BOM: 500087 | NSE: CIPLA
Share Price & Financials of BIOCON LTD | BOM: 532523 | NSE: BIOCON
Check out Quarterly Results of Industry Peers
Quarterly Results of SUN PHARMACEUTICAL INDUSTRIES LTD
Quarterly Results of DR REDDYS LABORATORIES LTD
Quarterly Results of DIVIS LABORATORIES LTD
Quarterly Results of CIPLA LTD
Quarterly Results of BIOCON LTD

What are the Frequent Comparisons in this Industry?

Compare Analytics
SUN PHARMACEUTICAL INDUSTRIES LTD vs DR REDDYS LABORATORIES LTD vs DIVIS LABORATORIES LTD
CIPLA LTD vs BIOCON LTD vs AUROBINDO PHARMA LTD
LUPIN LTD vs TORRENT PHARMACEUTICALS LTD vs CADILA HEALTHCARE LTD
ABBOTT INDIA LTD vs ALKEM LABORATORIES LTD vs PIRAMAL ENTERPRISES LTD
GLAXOSMITHKLINE PHARMACEUTICALS LTD vs IPCA LABORATORIES LTD vs PFIZER LTD
Browse Market Cap of Industry Peers
Market Cap of SUN PHARMACEUTICAL INDUSTRIES LTD
Market Cap of DR REDDYS LABORATORIES LTD
Market Cap of DIVIS LABORATORIES LTD
Market Cap of CIPLA LTD
Market Cap of BIOCON LTD

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z